News and Announcements
Rublix’s HedgeTrade Leaderboard Featuring Best Traders is now LIVE!
- Published March 02, 2020 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
HedgeTrade, built by Rublix, is a predictions marketplace that has elements of social trading, social media and betting — the platform is starting with trading predictions, and will be expanding into eSports and sports betting.
Now, they are very excited to introduce the HedgeTrade Leaderboard. This visual and interactive list features the top traders on HedgeTrade. It’s where the most accurate and successful traders rise to the top so new users can find them and start trading like a pro.
To read more on the HedgeTrade platform click here.
To read an article about HedgeTrade on PR Newswire click here.
About Rublix
Rublix is lead by an extensive team of software engineers, mathematicians and data scientists whose broad market experiences help them create the most relevant financial tools in modern trading. Rublix has a staff of over 30 full-time team members with offices in Canada, Europe and Asia.
Rublix is a FinTech company building blockchain powered tools that improve trading performance and efficiencies. The team is committed to creating meaningful applications that enhance trust, transparency and profitability. The ecosystem of products target both the retail customer and institutions alike.
Company Updates
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Dying for a Cure: Why Astraea is Stress-Testing the Future of Space Medicine
Astraea Technologies is solving a critical “blind spot” in the $1.5T space economy. Co-founders Brooke Mills and Gordon Carroll discuss their $5M seed raise, the HIRO-LAB platform, and their upcoming 2028 mission to the Moon to validate life-saving medicine in extreme environments.
Backed By Leading Investment Groups and Family Offices
